Hemophilia of Georgia Revenue and Competitors

Atlanta, GA USA

Location

N/A

Total Funding

NonProfit

Industry

Estimated Revenue & Valuation

  • Hemophilia of Georgia's estimated annual revenue is currently $35M per year.(i)
  • Hemophilia of Georgia's estimated revenue per employee is $486,111

Employee Data

  • Hemophilia of Georgia has 72 Employees.(i)
  • Hemophilia of Georgia grew their employee count by 7% last year.

Hemophilia of Georgia's People

NameTitleEmail/Phone
1
Social WorkerReveal Email/Phone
2
Pharmacy Technician - OperationsReveal Email/Phone
3
Revenue cycleReveal Email/Phone
4
Outreach RNReveal Email/Phone
5
ControllerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A5934%N/AN/A
#2
$15M376%N/AN/A
#3
$3.5M10N/AN/AN/A
#4
$3.5M327%N/AN/A
#5
$300M207643%N/AN/A
#6
$35M65-2%N/AN/A
#7
N/A4211%N/AN/A
#8
$7.5M47-2%N/AN/A
#9
N/A21538%N/AN/A
#10
$35M727%N/AN/A
Add Company

What Is Hemophilia of Georgia?

Hemophilia of Georgia is a nonprofit organization dedicated to providing services and support for people who have hemophilia, von Willebrand Disease, and other inherited bleeding disorders. The only agency of its kind in the state, Hemophilia of Georgia works to enhance clients' care and quality of life while actively pursuing a cure through research funding. Medical disclaimer: Hemophilia of Georgia is not engaged in the practice of medicine and does not endorse or support any particular factor concentrate or treatment protocol. HoG recommends that you consult with your physician prior to starting any course of therapy. Occasionally HoG disseminates information on new treatments or therapies. HoG shares this for informational purposes only and makes no claim as to its accuracy or effectiveness.

keywords:N/A

N/A

Total Funding

72

Number of Employees

$35M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$18.7M72N/AN/A
#2
$13.7M7633%N/A
#3
$18.5M775%N/A
#4
$11.8M848%$62M
#5
N/A937%N/A